Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jianfei Tu

Showing results (21-30 of 106) with videos related to

Pageof 11
Sort By:
Journal of Cancer Research and Therapeutics|September 26, 2018
Liver abscess following transarterial chemoembolization for the treatment of hepatocellular carcinoma: A retrospective analysis of 23 casesZhongzhi Jia, Jianfei Tu, Chuanwu Cao, et al.
Cancer Biotherapy & Radiopharmaceuticals|June 20, 2020
Iodine-125 Brachytherapy Can Prolong Progression-Free Survival of Patients with Locoregional Recurrence and/or Residual Hepatocellular Carcinoma After Radiofrequency AblationLi Chen, Xihui Ying, Dengke Zhang, et al.
Molecular Medicine Reports|April 24, 2020
Circular RNA Circ100084 functions as sponge of miR‑23a‑5p to regulate IGF2 expression in hepatocellular carcinomaJie Yang, Ying Li, Zuochun Yu, et al.
BMC Infectious Diseases|January 30, 2016
Multifocal musculoskeletal tuberculosis mimicking multiple bone metastases: a case reportMeiping Ye, Jinwei Huang, Jie Wang, et al.
Journal of Cellular Physiology|November 30, 2018
LINC00707 contributes to hepatocellular carcinoma progression via sponging miR-206 to increase CDK14Jianfei Tu, Zhongwei Zhao, Min Xu, et al.
Medicine|December 9, 2016
The incidence and outcome of major complication following conventional TAE/TACE for hepatocellular carcinomaJianfei Tu, Zhongzhi Jia, Xihui Ying, et al.
Cell Biochemistry and Biophysics|October 9, 2014
Effectiveness of combined (131)I-chTNT and radiofrequency ablation therapy in treating advanced hepatocellular carcinomaJianfei Tu, Jiansong Ji, Fazong Wu, et al.
Translational Cancer Research|February 4, 2022
Drug-eluting beads-transcatheter arterial chemoembolization with or without iodine-125 treatment is effective and tolerable in treating advanced non-small cell lung cancer patients: a pilot studyZhongwei Zhao, Jianfei Tu, Xiaoxi Fan, et al.
European Journal of Clinical Pharmacology|March 13, 2025
Evaluation of surrogate endpoints in phase III randomized control trials of advanced hepatocellular carcinoma treated with immune checkpoint inhibitorsKe Jiang, Miaowen Liu, Xiao Zhao, et al.
International Journal of Molecular Sciences|May 25, 2024
Synergy of Oxygen Vacancy and Surface Modulation Endows Hollow Hydrangea-like MnCo<sub>2</sub>O<sub>4.5</sub> with Enhanced Capacitive PerformanceGaofeng Li, Yanyan Li, Pengfei Wang, et al.
Pageof 11

Showing results (21-30 of 106) with videos related to

Sort By:
Pageof 11
Journal of Cancer Research and Therapeutics|September 26, 2018
Liver abscess following transarterial chemoembolization for the treatment of hepatocellular carcinoma: A retrospective analysis of 23 casesZhongzhi Jia, Jianfei Tu, Chuanwu Cao, et al.
Cancer Biotherapy & Radiopharmaceuticals|June 20, 2020
Iodine-125 Brachytherapy Can Prolong Progression-Free Survival of Patients with Locoregional Recurrence and/or Residual Hepatocellular Carcinoma After Radiofrequency AblationLi Chen, Xihui Ying, Dengke Zhang, et al.
Molecular Medicine Reports|April 24, 2020
Circular RNA Circ100084 functions as sponge of miR‑23a‑5p to regulate IGF2 expression in hepatocellular carcinomaJie Yang, Ying Li, Zuochun Yu, et al.
BMC Infectious Diseases|January 30, 2016
Multifocal musculoskeletal tuberculosis mimicking multiple bone metastases: a case reportMeiping Ye, Jinwei Huang, Jie Wang, et al.
Journal of Cellular Physiology|November 30, 2018
LINC00707 contributes to hepatocellular carcinoma progression via sponging miR-206 to increase CDK14Jianfei Tu, Zhongwei Zhao, Min Xu, et al.
Medicine|December 9, 2016
The incidence and outcome of major complication following conventional TAE/TACE for hepatocellular carcinomaJianfei Tu, Zhongzhi Jia, Xihui Ying, et al.
Cell Biochemistry and Biophysics|October 9, 2014
Effectiveness of combined (131)I-chTNT and radiofrequency ablation therapy in treating advanced hepatocellular carcinomaJianfei Tu, Jiansong Ji, Fazong Wu, et al.
Translational Cancer Research|February 4, 2022
Drug-eluting beads-transcatheter arterial chemoembolization with or without iodine-125 treatment is effective and tolerable in treating advanced non-small cell lung cancer patients: a pilot studyZhongwei Zhao, Jianfei Tu, Xiaoxi Fan, et al.
European Journal of Clinical Pharmacology|March 13, 2025
Evaluation of surrogate endpoints in phase III randomized control trials of advanced hepatocellular carcinoma treated with immune checkpoint inhibitorsKe Jiang, Miaowen Liu, Xiao Zhao, et al.
International Journal of Molecular Sciences|May 25, 2024
Synergy of Oxygen Vacancy and Surface Modulation Endows Hollow Hydrangea-like MnCo<sub>2</sub>O<sub>4.5</sub> with Enhanced Capacitive PerformanceGaofeng Li, Yanyan Li, Pengfei Wang, et al.
Pageof 11